Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Spero Therapeutics (SPRO) Prepaid Assets (2016 - 2025)

Spero Therapeutics (SPRO) has disclosed Prepaid Assets for 10 consecutive years, with $1.2 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Prepaid Assets fell 39.27% year-over-year to $1.2 million, compared with a TTM value of $1.2 million through Sep 2025, down 39.27%, and an annual FY2024 reading of $1.9 million, down 54.26% over the prior year.
  • Prepaid Assets was $1.2 million for Q3 2025 at Spero Therapeutics, down from $1.3 million in the prior quarter.
  • Across five years, Prepaid Assets topped out at $8.8 million in Q4 2021 and bottomed at $1.2 million in Q3 2025.
  • Average Prepaid Assets over 5 years is $4.2 million, with a median of $3.7 million recorded in 2024.
  • The sharpest move saw Prepaid Assets tumbled 74.2% in 2022, then skyrocketed 263.44% in 2023.
  • Year by year, Prepaid Assets stood at $8.8 million in 2021, then crashed by 61.73% to $3.4 million in 2022, then rose by 23.65% to $4.2 million in 2023, then tumbled by 54.26% to $1.9 million in 2024, then plummeted by 34.69% to $1.2 million in 2025.
  • Business Quant data shows Prepaid Assets for SPRO at $1.2 million in Q3 2025, $1.3 million in Q2 2025, and $1.5 million in Q1 2025.